Literature DB >> 16252073

Interaction analysis between 5-HTTLPR and TNFA -238/-308 polymorphisms in schizophrenia.

C-U Pae1, A Serretti, P Artioli, T-S Kim, J-J Kim, C-U Lee, S-J Lee, I-H Paik, C Lee.   

Abstract

This study investigated the potential interaction between the polymorphisms of serotonin transporter gene (SLC6A4, a 44 base pair insertion/deletion in the promoter region, 5-HTTLPR) and tumor necrosis factor-alpha gene (TNFA; -238G/A and -308G/A polymorphisms) on the development of schizophrenia, as well as the interaction of the three polymorphisms in relation to symptomatology, family history, onset age and antipsychotic treatment response. Genomic DNA analyses with polymerase chain reaction (PCR) was used for the genotyping. One hundred and fifty-two (152) patients with schizophrenia and 152 normal controls participated in the study. Any associations between the individual polymorphism and schizophrenia were not found. However, marginal association between subjects with both TNFA -238 A allele (genotype AA plus AG) and 5-HTTLPR s allele (ss plus sl) and presence of family history was found (p = 0.023; p = 0.026). The subjects with TNFA -308 AG genotype showed higher change in PANSS total score (p = 0.028). No significant interaction effect between 5-HTTLPR and TNFA -238/-308 polymorphisms either on the development of schizophrenia or on antipsychotics treatment response and psychopathology was found, although a significant interaction effect for subjects carrying TNFA -238 AG and -308 AA genotypes on a positive family history was observed (p = 0.017). These results suggest that the interaction effects between 5-HTTLPR and TNFA -238/-308 polymorphisms gives no significant contribution to the susceptibility to schizophrenia, and is not associated with clinical variables, antipsychotic treatment response and psychopathological features, except for family history of disease, at least in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16252073     DOI: 10.1007/s00702-005-0358-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  48 in total

1.  The serotonin transporter and clozapine response.

Authors:  M J Arranz; A A Bolonna; J Munro; C J Curtis; D A Collier; R W Kerwin
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

Review 2.  The main features of central 5-HT1 receptors.

Authors:  M Hamon; L Lanfumey; S el Mestikawy; C Boni; M C Miquel; F Bolaños; L Schechter; H Gozlan
Journal:  Neuropsychopharmacology       Date:  1990 Oct-Dec       Impact factor: 7.853

3.  Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia.

Authors:  J R Mendes de Oliveira; P A Otto; H Vallada; V Lauriano; H Elkis; B Lafer; L Vasquez; V Gentil; M R Passos-Bueno; M Zatz
Journal:  Am J Med Genet       Date:  1998-05-08

4.  No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia.

Authors:  Michael Riedel; Holger Krönig; Markus J Schwarz; Rolf R Engel; Kai-Uwe Kühn; Christopher Sikorski; Safet Sokullu; Manfred Ackenheil; Hans-Jürgen Möller; Norbert Müller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2002-10       Impact factor: 5.270

5.  No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus.

Authors:  L Naylor; B Dean; A Pereira; A Mackinnon; A Kouzmenko; D Copolov
Journal:  Mol Med       Date:  1998-10       Impact factor: 6.354

6.  A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha.

Authors:  A G Wilson; C Gordon; F S di Giovine; N de Vries; L B van de Putte; P Emery; G W Duff
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

7.  No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine.

Authors:  Shih-Jen Tsai; Chen-Jee Hong; Younger W-Y Yu; Ching-Hua Lin; Ling-Ling Liu
Journal:  Schizophr Res       Date:  2003-12-01       Impact factor: 4.939

8.  Linkage mapping of serotonin transporter protein gene SLC6A4 on chromosome 17.

Authors:  J Gelernter; A J Pakstis; K K Kidd
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

9.  Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.

Authors:  A B Erbağci; H Herken; O Köylüoglu; N Yilmaz; M Tarakçioglu
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  1 in total

1.  Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis.

Authors:  Feng-Ling Xu; Bao-Jie Wang; Jun Yao
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-28       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.